EPICENTRE™ BiotechnologiesEPICENTRE™ Biotechnologies
EPICENTRE™ Biotechnologies
Log In
 

TargetAmp™ Protocol Frequently Asked Questions (FAQs)

Order Now | Protocol | TargetAmp Process | TargetAmp Performance | TargetAmp FAQs | TargetAmp Poster

Question

Answer

1. What is the best RNA purification method to use to get total RNA for the TargetAmp Kit?

Total cellular RNA, isolated by a number of methods, including salt-fractionation (for example EPICENTRE's ArrayPure™ and MasterPure™ RNA purification kits), TRIzol® / TRI Reagent and spin columns, can be amplified successfully using the TargetAmp RNA Amplification Kits. However, it is very important that the purified RNA be free of salts, metal ions, ethanol and phenol which can inhibit the enzymatic reactions performed in the RNA amplification process. Details of total RNA isolation methods are presented in the TargetAmp Kit product literature that accompanies each kit and is available on this web site.

2. When should I use a TargetAmp 1-Round kit and when should I use a TargetAmp 2-Round Kit?

The TargetAmp 1-Round Kits should be used when amplifying RNA from 25 ng to 500 ng of total RNA. Use the TargetAmp 2-Round kits when amplifying from 10 pg to 500 pg of total RNA. See the TargetAmp Selection Guide web page for additional information.

3. Is it possible to scale up or scale down the TargetAmp RNA amplification reaction?

We do not recommend scaling the TargetAmp reactions up or down. The procedure is highly optimized. Trying to get more RNA or trying to work with low volumes may lead to sample loss or lower than expected yields.

4. Why does EPICENTRE recommend doing the second strand cDNA synthesis reaction at 65°C? Other commercial kits and published procedures use 16°C.

The TargetAmp Kits incorporate a unique, proprietary, highly-processive thermostable DNA Polymerase to make the second strand of the cDNA, rather than a mesophilic enzyme.

5. Why do you recommend using SuperScript II instead of SuperScript III during the second round of amplification in the first-strand cDNA synthesis?

During the second round of amplification, using high temperature reverse transcription to achieve more full-length cDNA is not as critical as in the first round of amplification. Using a mesophilic reverse transcriptase such as SuperScript II generates higher yields of cDNA than with SuperScript III.

6. At which steps in the TargetAmp RNA amplification process can I stop?

The stopping points are following the 2nd-strand cDNA synthesis steps, after DNase I treatment of the in vitro transcribed aRNA (just prior to the aRNA purification steps) and after the aRNA purification steps. If you choose to stop at the cDNA step you could save your sample at -20°C. We typically store our aRNA samples at -80°C.

7. Will there be a benefit if I increase the in vitro transcription reaction times.

No. The in vitro transcription reaction times are optimized to produce the highest yield of long aRNA. Running the reactions longer will begin to significantly reduce the NTP pool and result in shorter aRNA products.

8. What is the best way to purify my aRNA or aminoallyl-aRNA after I have completed the one amplification round or two amplification round procedures?

The purification column to use is dependent on the expected yield of aRNA or aminoallyl-aRNA (AA-aRNA). If the expected yield is <40 µg, purify the aRNA or AA-aRNA using the Qiagen MinElute Cleanup Kit (Qiagen cat. no. 74204) . If the expected yield of aRNA or AA-aRNA is >40 µg, use the Qiagen RNeasy Mini Kit. Details are provided in the TargetAmp Kit product literature.

9. If I perform the in vitro transcription reactions using a thermocycler, can I add a 4°C overnight "hold" and continue with the aRNA purification the following day?

Yes, this is typically what we do.

10. In the TargetAmp2-Round amplification protocol the volume is adjusted to 3 ul using speed vacuum just prior to the 2nd-round 1st-strand cDNA synthesis step.

a) Can I use a MicroCon concentrator instead?

b) What will happen if I reduce the volume to less than 3 ul?

c) What will happen if I accidentally dry the reaction?

a) We do not recommend the use of a microconcentrator system, for two reasons. First, the molecular weight cutoff of most of the micro concentrators is too high. It is possible to lose some of your short messenger RNAs through the pores of the concentrator membranes, which will destroy the accuracy of your microarray analysis using the amplified RNA. Further, elution of concentrated RNA requires 15 µl of buffer. This volume is too great to be used in the standard first strand cDNA synthesis reaction.

b) If the volume is dried to 1 µl to 3 µl, you should add RNase-free water to bring it back to 3 ul.

c) The result of completely drying the aRNA sample may be lower than expected yield of aRNA after the 2nd-round amplification because it may be difficult to dissolve dried aRNA in 3µl of RNase-free water or you may "miss" your aRNA when you add 3 ul of RNase-free water.

11. The aRNA purification steps read "remove any remaining solution from the column using a vacuum apparatus". If we do not have a vacuum apparatus, could we use a longer centrifugation instead?

Yes, spin it for an extra minute or two and just look to see if the column appears to be dry, no droplets of water) in the inner surface of the column.

17. What is the advantage of producing aminoallyl-aRNA rather than direct incorporation of a biotin-NTP, Cy-NTP or other fluorescent dye-NTP into the in vitro transcription reaction?

The aminoallyl-method for indirect labeling of the target nucleic acid is becoming increasingly popular because it has important advantages over direct incorporation of a biotin-NTP or fluorescent-NTP, including:

  • A single RNA amplification reaction, producing aminoallyl-aRNA, can be divided and labeled independently with different NHS-ester (e.g. Cy3-NHS and Cy5-NHS) if desired.
  • An aminoallyl-NTP is more efficiently incorporated into the aRNA during the in vitro transcription reaction resulting in higher yields of aminoallyl-aRNA than can be obtained by direct incorporation of a biotin-NTP or a fluorescent-NTP.
  • Conjugation of an amine-reactive biotin-NHS, Cy-NHS or other fluorescent dye-NHS to AA-aRNA is a much less expensive way to label the target compared to direct incorporation of a biotin-NTP, Cy-NTP or fluorescent dye-NTP.
  • Inexpensive Biotin-X-X-NHS, Cy-NHS and fluorescent dye-NHS labeling reagents are commercially available.

[top of page]


HOME | PRODUCTS | WHAT'S NEW | ORDERING | TECHNICAL RESOURCES | CONTACT US | ABOUT US

EPICENTRE® Biotechnologies—Enzyme Systems for RNA and DNA Research
©2008 EPICENTRE Biotechnologies. All Rights Reserved.